These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12518895)

  • 1. Mechanisms of alloimmune tolerance associated with mixed chimerism induced by vascularized bone marrow transplants.
    Ramsamooj R; Llull R; Patel MP; Beko KR; Black KS; Hewitt CW
    Cell Transplant; 2002; 11(7):683-93. PubMed ID: 12518895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants.
    Llull R; Ramsamooj R; Black KS; Hewitt CW
    Transpl Int; 1994; 7 Suppl 1():S453-6. PubMed ID: 11271279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
    Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
    Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of in situ IL-2r and TGF-beta expression in tolerant vascularized bone marrow (limb) transplant chimeras.
    Tatem LD; Hirpara S; Dalsey RM; Iannacone WM; DeLong WG; Hewitt CW
    Transplant Proc; 1997 Jun; 29(4):2194-5. PubMed ID: 9193586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients.
    Yazdi B; Patel MP; Ramsamooj R; Llull R; Achauer BM; Black KS; Hewitt CW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):739-40. PubMed ID: 1990672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts.
    Hewitt CW; Ramsamooj R; Patel MP; Yazdi B; Achauer BM; Black KS
    Transplantation; 1990 Nov; 50(5):766-72. PubMed ID: 2238052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
    Timrott K; Beetz O; Oldhafer F; Klempnauer J; Vondran FWR; Jäger MD
    PLoS One; 2020; 15(5):e0233497. PubMed ID: 32442182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation".
    Tsoulfas G
    J Surg Res; 2013 Nov; 185(1):e59-60. PubMed ID: 22656036
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Tetteh HA
    J Surg Res; 2013 Aug; 183(2):544-5. PubMed ID: 22677610
    [No Abstract]   [Full Text] [Related]  

  • 15. iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.
    Ishii R; Hirai T; Miyairi S; Omoto K; Okumi M; Ishii Y; Tanabe K
    Am J Transplant; 2018 Feb; 18(2):328-340. PubMed ID: 28766890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimerism studies as an approach for the induction of tolerance to extremity allografts.
    Muramatsu K; Kuriyama R; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
    J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1009-15. PubMed ID: 18573704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.
    Jin Y; Zhang Q; Hao J; Gao X; Guo Y; Xie S
    Immunology; 2003 Oct; 110(2):275-86. PubMed ID: 14511242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
    Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
    Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
    Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
    J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host disease in extremity transplantation: digital image analysis of bone marrow in situ.
    Hewitt CW; Englesbe MJ; Tatem LD; Strande LF; Doolin EJ; Dalsey RM; DeLong WG
    Ann Plast Surg; 1995 Jul; 35(1):108-12. PubMed ID: 7574277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.